APA (7th ed.) Citation

DL, O., E, P., N, B., A, F., P, L., CT, L., . . . JT, G. (2022). Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069. Journal of medicinal chemistry, 65(21), 14843. https://doi.org/10.1021/acs.jmedchem.2c01379

Chicago Style (17th ed.) Citation

DL, Orsi, et al. "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069." Journal of Medicinal Chemistry 65, no. 21 (2022): 14843. https://doi.org/10.1021/acs.jmedchem.2c01379.

MLA (9th ed.) Citation

DL, Orsi, et al. "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069." Journal of Medicinal Chemistry, vol. 65, no. 21, 2022, p. 14843, https://doi.org/10.1021/acs.jmedchem.2c01379.